State Street Corp Moderna, Inc. Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Moderna, Inc. stock. As of the latest transaction made, State Street Corp holds 16,847,212 shares of MRNA stock, worth $622 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
16,847,212
Previous 15,023,936
12.14%
Holding current value
$622 Million
Previous $1.78 Billion
36.89%
% of portfolio
0.05%
Previous 0.08%
Shares
19 transactions
Others Institutions Holding MRNA
# of Institutions
952Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.57 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.49 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$944 Million0.07% of portfolio
-
Theleme Partners LLP London, X07.23MShares$267 Million28.47% of portfolio
-
Geode Capital Management, LLC Boston, MA7.07MShares$261 Million0.04% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...